Effect of Supplementing a Mixed Macronutrient Beverage With Graded Doses of Leucine on Myofibrillar Protein Synthesis
Launched by MCMASTER UNIVERSITY · Jun 20, 2013
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
The processes of muscle protein synthesis (MPS) and muscle protein breakdown (MPB) occur concurrently. This constant protein turnover allows the muscle fiber to change its protein structure if loading demands or diet changes. The plasticity of skeletal muscle to respond to altered loading and contractile patterns is evidence of the capacity for remodeling that a fiber can undergo. It is quite well documented for example that mitochondrial content increases with endurance-type work. In contrast, heavier loading leads to less change in mitochondrial content but increases in myofibrillar prote...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male
- • Healthy and physically active (as determined by medical and activity questionnaire)
- • 18-35 years of age
- • 70-90 kg body mass
- • Having given informed consent
- Exclusion Criteria:
- • Exhibiting health risk factors as identified on the health screening questionnaire
- • Having any identified metabolic or intestinal disorders
- • Tobacco use
- • Aspirin use in the 4 days prior to the experimental trial
- • Consumption of prescription medications or any performance enhancing agent
- • Inability to endure the strenuous exercise bouts e.g. injuries
- • Alcohol intake during the 48 hours prior to each of the testing days
- • Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study
- • Have given blood in the last three weeks
- • Verbal confirmation that they have used a substance on the WADA banned list within the last year
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Ontario, Canada
Patients applied
Trial Officials
Stuart M Phillips, PhD
Principal Investigator
McMaster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials